2017 Blogging Technical Review 
TechCrunch LA
JUNE 10, 2020
Some firms have said that they’re going to turn to HBCUvc , a nonprofit organization that helps students from historically Black colleges and universities enter venture and tech. The program is expanding to Chicago in 2021, the blog post notes. Read the whole HBCUvc blog post here.
TechCrunch LA
APRIL 12, 2018
seems like an unlikely place to grow one of the next billion-dollar startups in the booming Los Angeles tech ecosystem. It was Iconiq that put a whopping $80 million into ServiceTitan just last year — and while the 2017 cash infusion may have been larger, the company’s valuation has continued to rise.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
JANUARY 3, 2018
One of the largest and most consequential data breaches in 2017 afflicted credit reporting agency Equifax, and it was hardly the only victim. The drumbeat of mishaps and scandals this year also included charges of sexual harassment and gender discrimination among tech companies and investors. Have all these.
Xconomy
NOVEMBER 13, 2016
View the Slideshow A little more than a year ago, amid a resurgence in San Diego’s software sector, Xconomy identified a baker’s dozen of local tech companies to watch in 2016. I met with Seed San Diego partners Taner Halicioglu and Eric Gasser, who also reviewed the companies and provided their feedback. I widened my net this year.
Xconomy
OCTOBER 7, 2016
military’s high-tech think tank DARPA described Safe Genes, a new program to fund safety measures that can be built into genome editing technology or counter its potential wayward effects. The funding could be as much as $100 million, and the first grants will be announced in 2017. —The U.S. THE ENVELOPE, PLEASE.
Xconomy
OCTOBER 5, 2016
The first round of pitches are due this week. “DARPA is saying you can’t retrofit [biosafety] into existing technology, you have to design it—not just into widgets and technologies, but into the institutions that are supporting the technologies.”
Xconomy
AUGUST 19, 2016
The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. Everyone is waiting until 2017, when huge studies of the drugs’ ability to prevent heart attacks and strokes start to provide data. Data from the other three trials should come in late 2016 or early 2017.
Expert insights. Personalized for you.
220 
Let's personalize your content